Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05568563Completed
Randomised, open-label trial of ethyl chloride in irreversible pulpitis (3 arms), sponsored by Altamash Institute of Dental Medicine. Primary endpoint: Intra-oral injection pain at 1 month. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05568563.